Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Lethal respiratory failure due to a surfactant protein C gene mutation
1,Department of Pediatrics Clinical Hospital Center Rijeka
2,Department of Neonatology Clinical Hospital Center Rijeka
3,Department of Paediatric Radiology Clinical Hospital Center Rijeka
4Department of Pathology School of Medicine, University of Rijeka
*Corresponding Author(s): SRAN BANAC E-mail: srdjan.banac@medri.hr
A case of a full-term male infant with recurrent episodes of „obstructive bronchitis” and „bilateral pneumonias”, refractory to conventional asthma therapy, is reported. When referred to the paediatric clinic at the age of 15 months, his clinical pre-sentation was of acute respiratory distress syndrome with severe hypoxemia, which was easily corrected by the inhalation of oxygen. A series of further investigations, including lung biopsy, suggested the diagnosis of childhood interstitial lung disease (ILD). Due to progressive respiratory failure, the boy died after 3 months of mechanical ventilator support, at the age of 19 months. Subsequently performed genetic studies revealed that he was heterozygous for the I73T mutation of the surfactant protein C precursor protein. Thus, suspicion of childhood ILD due to genetic mutations that influence surfactant metabolism should be raised in children who present with unexplained respiratory distress or chronic respiratory symptoms. Less invasive testing, such as surfactant protein genetics, may be diagnostic in such cases.
child, interstitial lung disease, respiratory distress, surfac-tant deficiency, surfactant protein C
SRAN BANAC,SANDRO DESSARDO,KRISTINA LAH-TOMULIĆ,NEVEN FRLETA ,NADA SINDIČIĆ-DESSARDO,GIORDANO ŠAINA,KSENIJA LUČIN . Lethal respiratory failure due to a surfactant protein C gene mutation. Signa Vitae. 2012. 7(2);47-49.
1. Redding GJ, Deterding RR, Fan LL. Interstitial lung disease. In: Taussig LM, Landau LI, editors. Pediatric respiratory medicine, 2nd ed. Philadelphia: Mosby; 2008. p. 661-9.
2. Springer C, Godfrey S. The approach to the child with apparent pediatric chronic lung disease. In: Kerem E, Canny GJ, Branski D, Levison H, editors. Advances in pediatric pulmonology. Pediatr Adolesc Med. Basel: Karger; 1997. vol 7. p. 125-37.
3. Clement A, Allen J, Corrin B, Dinwiddie V, Ducou le Pointe H, Eber E, et al. Task force on chronic interstitial lung disaese in immunocom-petent children. Eur Respir J 2004;24:686-697.
4. Bush A, Nicholson AG. Paediatric interstitial lung disease. Eur Respir Mon 2009;46:319-354.
5. Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, Wert SE, et al. A common mutation in the surfactant protein C gene asso-ciated with lung disease. J Pediatr 2005;146:370-375.
6. Bush A. Paediatric interstitial lung disease: not just kid´s stuff. Eur Respir J 2004;24;521-523.
7. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene mutation. Pediatr Res 2007;62:176-179.
8. Clement A, Eber E. Interstitial lung diseases in infants and children. Eur Respir J 2008;31:658-666.
Science Citation Index Expanded (SCIE) (On Hold)
Chemical Abstracts Service Source Index
Scopus: CiteScore 1.3 (2024)
Embase
Top